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Isodon rosthornii1. Introduction
Isodon is a cosmopolitan and important genus of Lamiaceae
family. The use of Isodon species in Chinese folk medicine has a
long tradition. Investigations proved Isodon species to be a pool
of diverse structures of diterpenoids with a range of bioac-
tivities,most ofwhichwere ent-kauranoids [1]. Thediscovery of
a series of compoundswith promising use in anti-inflammatory
and anti-tumors, such as eriocalyxin B [2,3], pharicin B [4],
oridonin [5], ponicidin [6], and adenanthin [7] further support-
ed their folk use and brought great attention.
Isodon rosthornii, used to treat rheumatism and sore
throat in Chinese folk therapy, was distributed in Sichuan
and Guizhou provinces of China [8]. Previous studies on this
species just led to the isolation of seven ent-kauranoids,
some of which showed anti-bacteria activity [8–13]. For the
secondary metabolites of the genus Isodon often differ whenx:+86 871 65216343.
u),
r B.V. Open access under CC BYgrows in different ecological environments, in continuation
of our effort to find bioactive substances, we explored the
plant indigenous to Qionglai City of Sichuan Province, which
had even not been studied on the secondary metabolites.
From the EtOAc section, two ent-atisanoids, including a new
one, isorosthornin D (1), and six ent-kauranoids including a
new 11,20-epoxy-ent-kauranoid (2), a new 3,20-epoxy-ent-
kauranoid (3) and a new enmein-type diterpenoid (4) were
isolated (Fig. 1). The absolute configuration of 1 were further
confirmed byX-ray diffraction study. In this paper,we reported
the isolation, stucture elucidation and the cytotoxic evaluation.
2. Experimental
2.1. General experimental procedures
Optical rotations were measured with a Horiba SEPA-300
polarimeter. UV spectra were obtained using a Shimadzu
UV-2401A spectrophotometer. A Tenor 27 spectrophotome-
ter was used for scanning IR spectroscopy with KBr pellets.
1D and 2D NMR spectra were recorded on Bruker AM-400
and DRX-500 spectrometers with TMS as internal standard.
Unless otherwise specified, chemical shifts (δ) were expressed
in ppm with reference to the solvent signals. HRESIMS was-NC-SA license.
Fig. 1. The structures of compounds 1–8.
Table 1
13C NMR data of compounds 1–4 (in C5D5N, δ in ppm, J in Hz)a.
No. 1 2 3 4
1 27.7 (t) 80.0 (d) 27.5 (t) 76.4 (d)
2 37.5 (t) 30.4 (t) 22.5 (t) 24.3 (t)
3 77.7 (d) 41.9 (t) 76.3 (d) 37.6 (t)
4 39.3 (s) 35.6 (s) 38.2 (s) 31.2 (s)
5 52.1 (d) 53.6 (d) 58.3 (d) 55.0 (d)
6 38.5 (t) 75.6 (d) 73.0 (d) 102.0 (d)
7 212.8 (s) 208.9 (s) 210.5 (s) 173.2 (s)
8 59.8 (s) 63.5 (s) 63.8 (s) 59.1 (s)
9 44.3 (d) 51.9 (d) 54.4 (d) 40.9 (d)
10 37.0 (s) 60.2 (s) 54.3 (s) 50.9 (s)
11 28.7 (t) 75.1 (d) 64.3 (d) 19.0 (t)
12 37.3 (d) 39.1 (t) 40.1 (t) 32.7 (t)
13 38.1 (t) 46.7 (d) 48.5 (d) 46.5 (d)
14 66.1 (d) 75.5 (d) 76.8 (d) 74.4 (d)
15 67.1 (d) 73.1 (d) 74.1 (d) 75.5 (d)
16 155.8 (s) 159.0 (s) 156.6 (s) 159.7 (s)
17 108.8 (t) 110.3 (t) 108.0 (t) 109.1 (t)
18 27.8 (q) 36.3 (q) 29.6 (q) 33.1 (q)
19 15.7 (q) 23.2 (q) 24.2 (q) 23.3 (q)
20
OMe
14.7 (q) 177.6 (s) 99.6 (d)
54.3
73.3 (t)
a NMR data of compounds 1, 4 were recorded at 100 MHz; data for
compounds 2 and 3 were recorded at 150 MHz. Assignments were made
based on DEPT, HSQC, COSY, HMBC, and ROESY experiments.
77R. Zhan et al. / Fitoterapia 88 (2013) 76–81performed on an API QSTAR time-of-flight spectrometer.
HREIMS was performed on a Waters Auto Spec Premier
P776 spectrometer. HSCCC was performed on TBE-300B.
Semipreparative HPLC was performed on an Agilent 1100
HPLC with a Zorbax SB-C18 (9.4 mm × 25 cm) column.
Column chromatography was performed with silica gel
(200–300 mesh, Qing-dao Marine Chemical, Inc., Qingdao,
China), Lichroprep RP-18 gel (40–63 μm, Merck, Darmstadt,
Germany) and MCI gel (75–150 μm, Mitsubishi Chemical
Corporation, Tokyo, Japan). Fractions were monitored by TLC,
and spotswere visualized by heating Si gel plates sprayedwith
5% H2SO4 in EtOH.
2.2. Plant material
The aerial parts of I. rosthorniiwere collected Qionglai City
of Sichuan Province, China, in July 2008, and was identified
by Prof. Xi-Wen Li, Kunming Institute of Botany. A voucher
specimen (KIB 200809003) has beendeposited in theHerbarium
of theKunming Institute of Botany, ChineseAcademyof Sciences.
2.3. Extraction and Isolation
The aerial parts (10 kg) of I. rosthornii were shade dried,
powdered, and extracted with the 70% aqueous acetone (20 L)
for four times (two days for each time) at room temperature.
The resulting extract was evaporated to be concentrated.
Then the concentrate without acetone (7 L) was partitioned
by EtOAc. The EtOAc soluble portion (485 g) was subjected to
column chromatography on a silica gel column (2000 g, 100–
200mesh) and elutingwith stepwise gradient of CHCl3-Me2CO
(1:0, 9:1, 8:2, 7:3, 6:4, 1:1) to afford five major fractions
(F1–F5). F2–F4 were first subjected to column chromatography
on MCI gel respectively, eluted with CH3OH:H2O 90:10. After
that, fraction 2was purified by repeat flash chromatography on
silica gel (200-300mesh, eluted with petroleum ether-acetone
30:1) to afford compound 6 (10 mg).
Fraction 3 (63 g) was separated by RP-18 gel column
chromatography (eluted with CH3OH:H2O 30:70–80:20
gradient) to yield four fractions (C1–C4). C1 was subjected
to HSCCC (CHCl3:CH3OH:H2O 4:3:2) and then was rechro-
matographed by silica gel, eluted with CHCl3:acetone 30:1
to give compound 1 (25 mg). C2 was purified by HSCCC
(CHCl3:MeOH:H2O 4:3:2) and then was separated by semi-
preparative HPLC with CH3OH:H2O 50:50 to afford com-
pounds 2 (2 mg), 5 (2 mg), and 8 (5 mg).Fraction 4 (85 g) was first chromatographed by Rp-18 gel
column chromatography with elution of CH3OH:H2O (30:70–
80:20 gradient) and then was subjected to HSCCC (CHCl3:
CH3OH:H2O 4:3:2). After that, silica gel column (eluted with
CHCl3:acetone 30:1) and semipreparative HPLC with elution
of CH3OH:H2O (50:50)were used to yield compounds 3 (2 mg),
4 (120 mg), and 7 (3 mg).
2.4. Spectroscopic data
Isorosthornin D (1), colorless crystals. [α]21 D = −24.7
(c = 0.68, MeOH). UV (MeOH): 203 (3.22) nm. IR (KBr):
3427, 2928, 2851, 1694, 1679, 1089, 1071, 1031 cm−1. NMR:
see Tables 1 and 2. HR-ESI-MS: 357.2031 ([M + Na]+,
C20H30O4Na; calc. 357.2041).
Isorosthornin E (2), colorless oil. [α]18.6 D = +41.4 (c =
1.6, MeOH). UV (MeOH): 204 (3.39), 289 (2.84) nm. IR (KBr):
3424, 2924, 1631, 1432, 1032 cm−1. NMR: see Tables 1 and
2. HR-EI-MS: 378.1663 ([M]+, C20H26O7; calc. 378.1679).
Isorosthornin F (3), white powder. [α]26.3 D = −97.5
(c = 0.51, MeOH). UV (MeOH): 204 (3.39) nm. IR (KBr):
3421, 2931, 1705, 1663, 1439, 1084, 1048 cm−1. NMR: see
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394.1992).
Isorosthornin G (4), white powder. [α]26.3 D = −75.3
(c = 1.00, MeOH). UV (MeOH): 202 (3.15), 254 (2.37) nm. IR
(KBr): 3417, 2948, 1716, 1060 cm−1. NMR: see Tables 1 and
2. HR-EI-MS: 364.1891 ([M]+, C20H28O6; calc. 364.1886).2.5. The cytotoxicity assay
The following human tumor cell lines were used: HL-60,
SMMC-7721, A-549, MCF-7 and SW-480whichwere obtained
from ATCC (Manassas, VA, USA). All the cells were cultured
in RPMI-1640 or DMEM medium (Hyclone, Logan, UT, USA),
supplemented with 10% fetal bovine serum (Hyclone) at
37 °C in a humidified atmosphere with 5% CO2. Cell viability
was assessed by conducting colorimetric measurements of
the amount of insoluble formazan formed in living cells
based on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, MO,
USA) [14]. Briefly, 100 μL of adherent cells were seeded into
eachwell of a 96-well cell culture plate and allowed to adhere
for 12 h before drug addition, while suspended cells were
seeded just before drug addition, both with an initial density
of 1 × 105 cells/mL in 100 μL medium. Each tumor cell line
was exposed to the test compound at various concentrations
in triplicate for 48 h, with cisplatin and paclitaxel (Sigma) as
positive controls. After the incubation, MTT (100 μg) was
added to each well, and the incubation continued for 4 h at
37 °C. The cells were lysed with 100 μL of 20% SDS-50% DMF
after removal of 100 μL medium. The optical density of the
lysate was measured at 595 nm in a 96-well microtiter plate
reader (Bio-Rad 680). The IC50 value of each compound was
calculated by the Reed and Muench's method [15].Table 2
1H NMR spectroscopic data (in C5D5N, δ in ppm, J in Hz) of compounds 1–4a.
No. 1 2
1a
1b
1.81 (m) 4.10 (dd, 10.5, 3.5
2a
2b
1.55 (m)
0.98 (overlapped)
2.43 (m)
1.84 (overlapped
3a
3b
3.77 (dd, 11.0, 4.8) 1.59 (m)
1.33 (overlapped
5 1.53 (m) 1.84 (overlapped
6 2.63 (br s) 5.19 (br s)
9 2.53 (m) 4.15 (d, 5.5)
11a 1.73 (m) 6.04(dd, 7.8, 5.5)
11b 1.45 (m)
12a 2.55 (m) 2.73 (m)
12b 2.08 (dd, 15.0, 7.8
13a 2.30 (ddd, 13.0, 9.0, 3.8) 3.04 (d, 7.8)
13b 1.85 (overlapped)
14 4.79 (dd,9.0, 3.8) 5.14 (br s)
15 5.77 (s) 6.51 (s)
17a
17b
5.52 (s)
5.23 (s)
5.70 (s)
5.32 (s)
18 1.04 (s) 1.34 (s)
19 0.97 (s) 1.90 (s)
20a
20b
1.11 (s)
OMe
a NMR data for compounds 1 and 4 were recorded at 500 MHz, and data of comp
DEPT, HSQC, COSY, HMBC, and ROESY experiments.2.6. X-ray crystal structure analysis
Colorless crystals of 1 were obtained in CH3OH. Intensity
data were collected at 100 K on a Bruker APEX DUO diffrac-
tometer equipped with an APEX II CCD, using Cu Kα radiation.
Cell refinement and data reductionwere performedwith Bruker
SAINT. The structures were solved by direct methods using
SHELXS-97 [16]. Refinements were performed with SHELXL-97
using full-matrix least-squares, with anisotropic displacement
parameters for all the non-hydrogen atoms. The H-atoms
were placed in calculated positions and refined using a riding
model. Molecular graphics were computed with PLATON.
Crystallographic data (excluding structure factor tables) for
the structures reportedhave beendepositedwith the Cambridge
Crystallographic Data Center as supplementary publications
no. CCDC 923358 for 1. Copies of the data can be obtained free
of charge on application to CCDC, 12 Union Road, Cambridge
CB 1EZ, UK [fax: Int. +44(0) (1223) 336 033); e-mail: deposit@
ccdc.cam.ac.uk].
Crystallographic data for compound (1): C20H30O4·H2O,
M = 352.46, orthorhombic, a = 7.19610(10) Å, b =
11.6805(2) Å, c = 21.1935(3) Å; α = 90.00°, β = 90.00°,
γ = 90.00°, V = 1781.40(5) Å3, T = 100(2) K, space group
P212121, Z = 4, 8453 reflections measured, 3070 independent
reflections (Rint = 0.0330). The final R1 values were 0.0345
(I > 2σ(I)). The final wR(F2) values were 0.0901 (I > 2σ(I)).
The final R1 values were 0.0345 (all data). The final wR(F2)
values were 0.0901 (all data). Flack parameter = −0.01(14).
3. Results and discussion
The EtOAc extract was subjected to repeated column
chromatography to afford eight diterpenoids, including four
new ones which were named as isorosthornins D–G (Fig. 1).3 4
) 2.52 (overlapped)
1.11 (m)
4.85 (overlapped)
)
1.97 (m)
1.80 (dd, 13.7, 11.5)
1.84 (m)
)
3.40 (m) 1.32 (m)
1.25 (m)
) 1.66 (d, 12.8) 2.26 (s)
4.90 (d, 12.8) 5.79 (s)
2.80 (br s) 4.02 (dd, 13.0, 6.6)
4.87 (overlapped) 2.22 (m)
1.65 (m)
2.54 (overlapped) 2.44 (m)
) 2.34 (d, 10.4) 1.86 (overlapped)
3.13 (br s) 2.06 (d, 8.0)
4.84 (br s) 4.87 (overlapped)
6.46 (d, 9.7) 6.39 (s)
5.66 (s)
5.41 (s)
5.67 (s)
5.25 (s)
1.12 (s) 1.06 (s)
1.61 (s) 1.02 (s)
5.66 (overlapped) 4.77 (d, 8.0)
4.28 (d, 8.0)
3.46 (s)
ounds 2 and 3 were recorded at 600 MHz; Assignments were made based on
Fig. 3. X-ray crystal structure of 1.
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by comparing spectroscopic data with literature values and
were identified as isorubesin E (5) [17], jianshirubesin D (6)
[18], rubescensin W (7) [19], and jianshirubesin E (8) [18].
Compound 1 was obtained as colorless crystals. Its
molecular formula was established as C20H30O4 by HR-ESI-MS
data (m/z 357.2031 [M + Na]+, calcd. 357.2041), indicating of
six degrees of unsaturation. Absorption bands at 3427, 1694,
and 1679 cm−1 in the IR spectrum accounted for the presence
of OH, C_O, and C_CH2 groups. In the 13C NMR and DEPT
spectra, 20 carbon signals were observed: including three
methyls, six methylenes (including an olefinic one), six
methines (including three oxygenated ones), and five quater-
nary carbons (including a carbonyl one and an olefinic one).
Considering main diterpenoids, ent-kauranoids from Isodon
species, compound 1 was first assumed to be a 20-non-
oxygenated-ent-kauranoid, while HMBC correlations observed
from H-9 (δH 2.53) and H2-17 (δH 5.52 and 5.23) to C-12
(δC 37.3) suggested it a rearranged 16(13→ 12)-abeo-ent-
kaurane skeleton (ent-atisane skeleton) [20]. With the 1H-1H
COSY, HSQC and HMBC spectra, the planar structure of 1 was
elucidated. The HMBC correlations fromH3-18 (δH 1.04) to C-3
(δC 77.7), fromH2-17 to C-15 (δC 67.1), H-9 and H-15 (δH 5.77)
to C-14 (δC 66.1) proved the linkage of OH groups to C-3,
C-14 and C-15, respectively. The HMBC correlations from H-5
(δH 1.53) and H-9 to C-7 (δC 212.8) permitted the location of
the carbonyl carbon at C-7 (Fig. 2). Therefore, 1was presumed
to be 3,14,15-trihydroxy-ent-atis-16-en-7-one.
The ROESY correlations helped assign the relative config-
uration of 1. Correlations of H-3/H-1β/H-5β, H-14/H3-20/
H-13α and H-15/H-13β confirmed H-3, H-14 and H-15 to be
β, α, and α-oriented, respectively (Fig. 2). To determine the
absolute configuration of 1, a single crystal of 1 was analyzed
by X-ray crystallography. Bearing on four oxygen atoms in
the molecular, the final refinement on Cu Kα data resulted in
a Flack parameter of −0.01 (14), allowing an unambiguous
assignment of the complete absolute configuration of 1 as
shown in its formula (Fig. 3) [21]. All chiral centers, C-3, C-5,
C-8, C-9, C-10, C-12, C-14 and C-15 were determined as R, S,
S, R, S, R, R and R, respectively. Therefore, compound 1 was
determined to be 3α,14β,15β-trihydroxy-ent-atis-16-en-7-one,
named as isorothornin D (1).Fig. 2. 1H–1H COSY, selected HMBC anThe molecular formula of 2 was determined as C20H26O7
on the basis of the HREIMS data. Analysis of the spectroscopic
data of 2 revealed it a 11,20-epoxy-ent-kauranoid, with extreme
similarity to 6 [18]. The only difference was an additional OH
substituted at C-14 in 2 which was deduced by the HMBC
correlations fromH-14 (δH 5.14) to C-9 (δC 51.9), C-12 (δC 39.1),
and C-16 (δC 159.0). The HMBC correlations from H2-3 (δH 1.59
and 1.33), H-5 (δH 1.84), andH-9 (δH 4.15) to C-1 (δC 80.0), from
H-6 (δH 5.19) to C-5 (δC 53.6) and C-8 (δC 63.5), and from H-15
(δH 6.51) to C-16 andC-17 (δC 110.3) confirmed the connections
of other three OH groups to C-1, C-6, and C-15, respectively, the
same as those in 6. The HMBC correlations from H-5, H-9, and
H-15 to the ketone carbonyl (δC 208.9), fromH-1 (δH 4.10), H-5,
and H-9 to the lactone carbonyl (δC 177.6) permitted the
location of the ketone and lactone carbonyls at C-7 and C-20,
respectively.
The ROESY experiment verified that the relative con-
figuration of H-1, H-6, H-11, and H-15 of compound 2
were β-, α-, β-, α-oriented, respectively, identical to com-
pound 6 (Fig. 4) [18]. The correlations of H-14/H-12α verified
H-14 to be α-oriented. Thus, compound 2 was elucidatedd key ROESY correlations of 1.
Fig. 4. Key ROESY correlations of 2.
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en-7-one, named as isorothornin E (2).
The HREIMS of compound 3 suggested the molecular
formula of C21H30O7, indicative of seven degrees of unsatu-
ration. The absorption bands at 3421, 1705, and 1663 cm-1 in
its IR spectrum revealed the existence of OH, C_O, and C_C
groups. In its 13C NMR and DEPT spectra (Table 1), 21 carbon
signals were observed, which were assigned to three
methyls (including an oxygenated one), four methylenes
(including an olefinic one), nine methines (including six
oxygenated ones), and five quaternary carbons (including a
carbonyl one and an olefinic one). These data suggested 3 to
be a 20-oxygenated ent-kauranoid which was further
proved by the 2D NMR spectra. The HMBC correlations
from H-3 (δH 3.40) to C-20 (δC 99.6) confirmed 3 to be a
3,20-epoxy-ent-kauranoid; correlations from OMe (δH 3.46)
to C-20 permitted the connection of OMe to C-20 directly;
correlations fromH-6 (δH 4.90) to C-4 (δC 38.2) andC-5 (δC 58.3),
from H-11 (δH 4.87) to C-13 (δC 48.5) and C-8 (δC 63.8), from
H-14 (δH 4.84) to C-9 (δC 54.4) and C-16 (δC 156.6), and from
H2-17 (δH 5.66 and 5.41) to C-15 (δC 74.1) verified the
linkage of OH groups to C-6, C-11, C-14 and C-15, respec-
tively; correlations from H-5 (δH 1.66) and H-15 (δH 6.46) to
C-7 (δC 210.5) permitted the location of the carbonyl carbon
at C-7 (Fig. 5). Consequently, compound 3 was assigned as
6,11,14,15-tetrahydroxy-20-methoxy-3,20-epoxy-ent-kaur-
16-en-7-one.Fig. 5. 1H–1H COSY, selected HMBC of 3.
Table 3
IC50 values (μM) of diterpenoids from I. rosthornii for human tumor cell lines.
Compounda HL-60 SMMC-7721 A-549 MCF-7 SW480
6 5.00 >40 30.11 16.22 22.62
DDPb 2.0 16.2 17.5 17.8 12.8
Paclitaxelb b0.008 b0.008 1.36 b0.008 0.04
a Other selected ones not listed in the table were inactive (IC50 > 40 μM)
for all cell lines.
b DDP (cisplatin) and paclitaxel were used as positive controls.The relative configuration of 3 was derived by the ROESY
spectrum. The correlations of H-3/H-1β/H-5β, H-6/H3-19α/
H-20, H-11/H-12α/H-OMe, H-14/H-20, and H-15/H-13α
confirmed H-3, H-6, H-11, H-14 and H-15 to be β-, α-, α-,
α-, and α-oriented, respectively. The R* configuration of C-20
was determined by the correlations from H-20 to H3-19α and
H-2α. As a result, 3 was characterized as 20(R*)-6β,11β,14β,
15β- tetrahydroxy-20-methoxy-3α,20-epoxy- ent-kaur-16-
en-7-one, named as isorothornin F (3).
Compound 4 was obtained as white amorphous powders.
The HREIMS of 4 exhibited a [M]+ peak at 364.1891, which
suggested the molecular formula of C20H28O6, indicating of
seven degrees of unsaturation. Its IR spectrum had absorption
bands at 3417, 1716 and 1060 cm−1, accounting for the
presence of OH, C_O, and C_C groups. In its 13C NMR and
DEPT spectra (Table 1), 20 carbon signalswere observed,which
were assigned to two methyls, six methylenes (including
an olefinic one and an oxygenated one), seven methines
(including four oxygenated ones), and five quaternary carbons
(including a carbonyl one and an olefinic). These data indicated
that 4 was a 6,7-seco-1,7-olide-ent-kauranoid, similar to
epinodosinol [22,23]. The only difference verified by the 1H-1H
COSY, HSQC, and HMBC spectra was the connection of OH to
C-14 instead of the one substituted at C-11 in epinodosinol. The
ROESY spectrum supported the same relative configurations of
H-1, H-6 and H-15 with epinodosinol. The configuration of H-14
was determined to be β-oriented by the ROESY correlation of
H-14/H-13β. Hence, 4was elucidated as 6β,14α,15α-trihydroxy-
6,7-seco-6,20-epoxy-1α,7-olide-ent-kaur-16-ene, named as
isorothornin G (4).
To the best of our knowledge, compounds 1 and 5 are the
first example of atisane-type diterpenoids from this plant.
Furthermore, those sub-types of ent-kauranoids, 11,20-epoxy-
ent-kauranoid (2 and 6-8), 3,20-epoxy-ent-kauranoid (3) and
enmein-type ent-kauranoid (4) were also isolated from Isodon
rosthornii for the first time.
Considering the folk use of the Isodon genus, these isolates
except 2 and 3 were tested for in vitro cytotoxicity against
A-549, HL-60, MCF-7, SMMC-7721, and SW-480 human
cancer cell lines using the MTT method [14]. Compound 6
showed significant inhibitory activity against HL-60 cell line
(Table 3).
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